JP2019514383A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019514383A5 JP2019514383A5 JP2018556896A JP2018556896A JP2019514383A5 JP 2019514383 A5 JP2019514383 A5 JP 2019514383A5 JP 2018556896 A JP2018556896 A JP 2018556896A JP 2018556896 A JP2018556896 A JP 2018556896A JP 2019514383 A5 JP2019514383 A5 JP 2019514383A5
- Authority
- JP
- Japan
- Prior art keywords
- palimumab
- acid
- lithium
- medium
- interleukin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021062942A JP2021112191A (ja) | 2016-04-26 | 2021-04-01 | 細胞培養培地 |
| JP2023101764A JP2023126248A (ja) | 2016-04-26 | 2023-06-21 | 細胞培養培地 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662327964P | 2016-04-26 | 2016-04-26 | |
| US62/327,964 | 2016-04-26 | ||
| PCT/US2017/029566 WO2017189679A1 (en) | 2016-04-26 | 2017-04-26 | Cell culture medium |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021062942A Division JP2021112191A (ja) | 2016-04-26 | 2021-04-01 | 細胞培養培地 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019514383A JP2019514383A (ja) | 2019-06-06 |
| JP2019514383A5 true JP2019514383A5 (https=) | 2020-06-18 |
| JP6982578B2 JP6982578B2 (ja) | 2021-12-17 |
Family
ID=60089387
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018556896A Active JP6982578B2 (ja) | 2016-04-26 | 2017-04-26 | 細胞培養培地 |
| JP2021062942A Pending JP2021112191A (ja) | 2016-04-26 | 2021-04-01 | 細胞培養培地 |
| JP2023101764A Pending JP2023126248A (ja) | 2016-04-26 | 2023-06-21 | 細胞培養培地 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021062942A Pending JP2021112191A (ja) | 2016-04-26 | 2021-04-01 | 細胞培養培地 |
| JP2023101764A Pending JP2023126248A (ja) | 2016-04-26 | 2023-06-21 | 細胞培養培地 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10703800B2 (https=) |
| EP (1) | EP3448982A4 (https=) |
| JP (3) | JP6982578B2 (https=) |
| AU (2) | AU2017255538B2 (https=) |
| CA (1) | CA3019400A1 (https=) |
| TW (1) | TWI734775B (https=) |
| WO (1) | WO2017189679A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR095196A1 (es) | 2013-03-15 | 2015-09-30 | Regeneron Pharma | Medio de cultivo celular libre de suero |
| TWI870789B (zh) | 2015-08-04 | 2025-01-21 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法 |
| KR101936049B1 (ko) | 2015-10-15 | 2019-01-08 | (주)알테오젠 | IgG Fc 도메인을 가지는 융합 단백질의 생산방법 |
| TWI734775B (zh) | 2016-04-26 | 2021-08-01 | 美商美國泰福生技股份有限公司 | 細胞培養基 |
| US10858422B2 (en) | 2016-05-31 | 2020-12-08 | Abcentra, Llc | Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody |
| US10434141B2 (en) | 2016-05-31 | 2019-10-08 | Abcentra, Llc | Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody |
| EP3635093A1 (en) * | 2017-06-08 | 2020-04-15 | Polpharma Biologics S.A. | Improved methods of cell culture |
| BR112020000127A2 (pt) * | 2017-07-06 | 2020-07-07 | Regeneron Pharmaceuticals, Inc. | método para selecionar um hidrolisado de soja, e, glicoproteína |
| CN108823267B (zh) * | 2018-06-25 | 2020-05-08 | 深圳市菲鹏生物制药股份有限公司 | 调节cho-k1表达系统所分泌抗体的酸性峰含量的方法 |
| JP7388722B2 (ja) * | 2018-08-10 | 2023-11-29 | 国立大学法人 東京大学 | アルギン酸中空マイクロファイバ |
| US12297451B1 (en) | 2019-10-25 | 2025-05-13 | Regeneron Pharmaceuticals, Inc. | Cell culture medium |
| AU2021262609A1 (en) | 2020-05-01 | 2022-12-22 | Kashiv Biosciences, Llc | An improved process of purification of protein |
| US20230166200A1 (en) * | 2020-05-01 | 2023-06-01 | Kashiv Biosciences, Llc | An improved process of purification of protein |
| WO2023058051A1 (en) * | 2021-10-04 | 2023-04-13 | Dr. Reddy's Laboratories Limited | Process to produce a pharmaceutical composition |
| CN120917038A (zh) * | 2023-03-23 | 2025-11-07 | 伊莱利利公司 | 生产含有Fc的蛋白质的方法 |
| CN116814532B (zh) * | 2023-07-10 | 2025-02-11 | 上海迈邦生物科技有限公司 | 一种用于哺乳动物细胞培养基的脂类复合物及其制备方法与应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378612A (en) | 1990-05-11 | 1995-01-03 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Culture medium for production of recombinant protein |
| GB9022545D0 (en) * | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
| CL2007002404A1 (es) * | 2006-08-21 | 2008-04-18 | Hoffmann La Roche | Uso de un anticuerpo anti-vegf (factor de crecimiento endotelial vascular) para el tratamiento de un paciente que padece una recaida de cancer her2 positivo durante o despues del tratamiento con un anticuerpo anti-her2. |
| PT2164866E (pt) * | 2007-05-29 | 2014-08-04 | Angiochem Inc | Polipéptidos de tipo aprotinina para administrar agentes conjugados com os mesmos aos tecidos |
| JP2009017847A (ja) * | 2007-07-13 | 2009-01-29 | Nipro Corp | 細胞培養培地の製造方法及び細胞培養培地 |
| DK2491385T3 (en) * | 2009-10-20 | 2017-08-28 | Diatech Holdings Inc | PROXIMITY-MEDIED ASSAYS FOR DETECTING ONCOGEN FUSION PROTEINS |
| EP2531592A1 (en) * | 2010-02-04 | 2012-12-12 | Vivalis | Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells |
| MX368546B (es) | 2011-05-20 | 2019-10-07 | Alderbio Holdings Llc | Producción en alta pureza de proteínas multi-subunitarias tales como anticuerpos en microbios transformados tal como pichia pastoris. |
| WO2013006461A1 (en) * | 2011-07-01 | 2013-01-10 | Biogen Idec Ma Inc. | Cholesterol-based media supplementals for cell culture |
| KR101519478B1 (ko) | 2013-07-25 | 2015-05-12 | 한국환경정책평가연구원 | 진공관과 냉각채널이 결합된 막 증류 수처리 장치 |
| KR20160125352A (ko) | 2013-12-20 | 2016-10-31 | 이센셜 파마수티컬스 엘엘씨 | 세포 배양용 배지 |
| KR101660580B1 (ko) * | 2014-04-02 | 2016-09-28 | 프레스티지 바이오파마 피티이. 엘티디. | 항체의 당 함량 조절을 통한 항체의 제조 방법 |
| US10227559B2 (en) | 2014-04-10 | 2019-03-12 | Bayer Healthcare Llc | Compounded media powder formulation and method of preparation of liquid medium for cell culture |
| KR101625595B1 (ko) * | 2014-04-30 | 2016-05-31 | 한국과학기술원 | 재조합 단백질 생산 증가를 위한 염화리튬을 포함하는 세포 배양용 배지 조성물 및 이의 용도 |
| TWI734775B (zh) | 2016-04-26 | 2021-08-01 | 美商美國泰福生技股份有限公司 | 細胞培養基 |
-
2017
- 2017-04-25 TW TW106113819A patent/TWI734775B/zh active
- 2017-04-26 AU AU2017255538A patent/AU2017255538B2/en active Active
- 2017-04-26 JP JP2018556896A patent/JP6982578B2/ja active Active
- 2017-04-26 CA CA3019400A patent/CA3019400A1/en active Pending
- 2017-04-26 US US15/498,221 patent/US10703800B2/en active Active
- 2017-04-26 EP EP17790317.6A patent/EP3448982A4/en not_active Withdrawn
- 2017-04-26 WO PCT/US2017/029566 patent/WO2017189679A1/en not_active Ceased
-
2020
- 2020-06-19 US US16/906,766 patent/US12173049B2/en active Active
-
2021
- 2021-04-01 JP JP2021062942A patent/JP2021112191A/ja active Pending
-
2022
- 2022-06-01 AU AU2022203779A patent/AU2022203779A1/en not_active Abandoned
-
2023
- 2023-06-21 JP JP2023101764A patent/JP2023126248A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019514383A5 (https=) | ||
| JP7273904B2 (ja) | 液性免疫応答の増強方法 | |
| US9556264B2 (en) | Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient | |
| TWI860447B (zh) | 細胞傷害誘導治療劑 | |
| JP2021104025A (ja) | Ｔｉｍ−３に対する抗体分子およびその使用 | |
| JP2011527896A5 (https=) | ||
| TW201619200A (zh) | 人類化抗－ｏｘ４０抗體及其用途 | |
| JP2010536396A5 (https=) | ||
| US11492372B2 (en) | Removal of leaked affinity purification ligand | |
| RU2012145183A (ru) | Антитела с повышенной или пониженной эффекторной функцией | |
| JP2013528357A5 (https=) | ||
| CN119823260A (zh) | 从人中分离过敏原特异性抗体的方法及其用途 | |
| CN116209676A (zh) | Lair-1结合剂及其使用方法 | |
| RU2016152693A (ru) | Способ культивирования клеток для получения белка | |
| CA2907358A1 (fr) | Nouveaux medicaments comprenant une composition d'anticorps enrichie en isoforme de charge majoritaire | |
| JP2021507689A5 (https=) | ||
| CN116194486A (zh) | 异二聚体Fc多肽 | |
| WO2023125729A1 (zh) | 一种抗cd3的人源化抗体及其在制备双特异性抗体中的应用 | |
| KR102800024B1 (ko) | 항-ｍｙｌ9 항체 | |
| HK1223567A1 (zh) | 含有人源化抗上皮调节蛋白抗体作爲有效成分的腺癌以外的非小细胞肺癌的治疗药 | |
| CN114340660A (zh) | 开发用于发现治疗性抗体的高效杂交瘤平台 | |
| JP2022103201A (ja) | 抗体可変領域の多様化を促進する方法 | |
| TW202003555A (zh) | 用於純化重組多肽之方法 | |
| LT2005043A (en) | Process for preparing monoclonal antibodies; hybridoma cell lines generated by this process and recombinant chimeric virus-like particles with inserted foreign protein fragments as immunogenes to generate hybridomas by this process | |
| TW202535925A (zh) | 具有增強的Ｆｃ受體結合之Ｆｃ結構域變體 |